<DOC>
	<DOCNO>NCT02766153</DOCNO>
	<brief_summary>Myeloproliferative disorder ( MPD ) include chronic myeloid leukemia ( CML ) ( Ph + ) essential thrombocythemia ( ET ) , polycythemia vera ( PV ) , myelofibrosis ( MF ) call SMP Ph . CML ultimate model carcinogenesis . SMP characterize malignant monoclonal proliferation pluripotent hematopoietic progenitor determine presence balance translocation chromosomes 9 22 ( Ph chromosome ) lead major change large number cell function . Investigators believe within bone marrow exist two type `` hematopoietic niche ' niche osteoblastic / endosteal vascular niche , control maintenance differentiation hematopoietic stem cell pool . The endosteal niche , hypoxic region near endosteal trabecular , provide protection deeply dormant stem cell . Data literature suggest SMP , especially CML , interaction malignant stem cell microenvironment niche Endosteal could favor survival resistance treatment . The therapeutic management CML upset use tyrosine kinase inhibitor ( TKIs ) . However , despite advance , even situation undetectable residual disease , observed relapse disease stop TKI leave suggest resistance leukemic stem cell TKI . Work group Bipoa `` Bio Engineering Pathophysiology Osteo-Articular '' help develop 3D model ex vivo bone formation , mimic endosteal niche . goal apply model SMP hematopoiesis refer normal hematopoiesis . test hypothesis endosteal ex vivo recess 3D modeling allows highlight special interaction promote persistence leukemia stem cell despite use effective therapy .</brief_summary>
	<brief_title>Exploring Mechanisms Resistance Stem Cells Myeloproliferative Opposite Tyrosine Kinase Inhibitors 3d Model Niche Endosteal</brief_title>
	<detailed_description />
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<criteria>Patients LLC ( chronic myeloid leukemia )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>